{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:24:37Z","timestamp":1792621477396,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s12022-008-9050-2","type":"journal-article","created":{"date-parts":[[2008,12,4]],"date-time":"2008-12-04T04:17:52Z","timestamp":1228364272000},"page":"221-225","source":"Crossref","is-referenced-by-count":73,"title":["Challenging Lesions in the Differential Diagnosis of Endocrine Tumors: Parathryoid Carcinoma"],"prefix":"10.1007","volume":"19","author":[{"given":"Ronald A.","family":"DeLellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,5]]},"reference":[{"key":"9050_CR1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","volume":"132","author":"RA DeLellis","year":"2008","unstructured":"DeLellis RA, Mazzalia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132:1251\u201362, 2008.","journal-title":"Arch Pathol Lab Med"},{"key":"9050_CR2","first-page":"224","volume-title":"Pathology and genetics of tumours of endocrine organs (WHO classification)","author":"L Bondeson","year":"2004","unstructured":"Bondeson L, Grimeluis L, DeLellis RA, et al. Parathyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PN, Eng C, eds. Pathology and genetics of tumours of endocrine organs (WHO classification). Lyon: IARC, pp. 224\u20137, 2004."},{"key":"9050_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.pap.0000151319.42376.d4","volume":"12","author":"RA DeLellis","year":"2005","unstructured":"DeLellis RA. Parathyroid carcinoma. An overview. Adv Anat Pathol 12:53\u20131, 2005. doi: 10.1097\/01.pap.0000151319.42376.d4 .","journal-title":"Adv Anat Pathol"},{"key":"9050_CR4","first-page":"1","volume":"86","author":"EH Norris","year":"1948","unstructured":"Norris EH. Collective review. Carcinoma of the parathyroid glands with a preliminary report of 3 cases. Int Abstracts of Surg 86:1\u201321, 1948.","journal-title":"Int Abstracts of Surg"},{"key":"9050_CR5","unstructured":"Castleman B. Tumors of the Parathyroid Glands. Atlas of Tumor Pathology. Section IV\u2014Fascicle 15. Armed Forces Institute of Pathology. Washington, DC 1952."},{"key":"9050_CR6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","volume":"31","author":"A Schantz","year":"1973","unstructured":"Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer 31:600\u20135, 1973. doi: 10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0 .","journal-title":"Cancer"},{"key":"9050_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ajcp\/75.3.345","volume":"75","author":"D Snover","year":"1981","unstructured":"Snover D, Foucar K. Mitotic activity in benign thyroid diseases. Am J Clin Pathol 75:345\u20137, 1981.","journal-title":"Am J Clin Pathol"},{"key":"9050_CR8","volume-title":"Tumors of the parathyroid glands. Atlas of tumor pathology, 3rd series, fascicle 6","author":"RA DeLellis","year":"1993","unstructured":"DeLellis RA. Tumors of the parathyroid glands. Atlas of tumor pathology, 3rd series, fascicle 6. Washington DC: Armed Forces Institute of Pathology, 1993."},{"key":"9050_CR9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(77)91414-3","volume":"1","author":"RL Reddick","year":"1977","unstructured":"Reddick RL, Costa J, Marx SJ. Parathyroid hyperplasia and parathyromatosis. Lancet 1:549, 1977. doi: 10.1016\/S0140-6736(77)91414-3 .","journal-title":"Lancet"},{"key":"9050_CR10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jcem-67-4-779","volume":"67","author":"KE Levin","year":"1988","unstructured":"Levin KE, Chew KL, Ljung BM. Deoxyribonucleic acid cytometry helps identify parathyroid carcinomas. J Clin Endocrinol Metab 67:770\u20134, 1988.","journal-title":"J Clin Endocrinol Metab"},{"key":"9050_CR11","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00000478-199308000-00007","volume":"17","author":"L Bondeson","year":"1993","unstructured":"Bondeson L, Sandelin K, Grimeluis L. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol 17:820\u20139, 1993. doi: 10.1097\/00000478-199308000-00007 .","journal-title":"Am J Surg Pathol"},{"key":"9050_CR12","doi-asserted-by":"crossref","first-page":"115A","DOI":"10.1038\/modpathol.3880502","volume":"15","author":"GE Guiter","year":"2002","unstructured":"Guiter GE, DeLellis RA. Risk of recurrence or metastasis in atypical parathyroid adenoma. Mod Pathol 15:115A, 2002, (Abstract).","journal-title":"Mod Pathol"},{"key":"9050_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0046-8177(95)90028-4","volume":"26","author":"GC Abbona","year":"1995","unstructured":"Abbona GC, Papotti M, Gasparri G, Bussolati G. Proliferative activity in parathyroid tumors as detected by KI-67 immunostaining. Hum Pathol 26:135\u20138, 1995. doi: 10.1016\/0046-8177(95)90028-4 .","journal-title":"Hum Pathol"},{"key":"9050_CR14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000478-199903000-00007","volume":"23","author":"LA Erickson","year":"1999","unstructured":"Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden LA, Lloyd RV. Parathyroid hyperplasia, adenomas and carcinoma: differential expression of p27kip1 protein. Am J Surg Pathol 23:288\u20135, 1999. doi: 10.1097\/00000478-199903000-00007 .","journal-title":"Am J Surg Pathol"},{"key":"9050_CR15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/hupa.2003.55","volume":"34","author":"A Stojadinovic","year":"2003","unstructured":"Stojadinovic A, Hoos A, Nissan A, et al. Parathyroid neoplasms; clinical, histopathological and tissue microarray-based molecular analysis. Hum Pathol 34:54\u20134, 2003. doi: 10.1053\/hupa.2003.55 .","journal-title":"Hum Pathol"},{"key":"9050_CR16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0002-9440(10)64568-3","volume":"157","author":"S Kytola","year":"2000","unstructured":"Kytola S, Farnebo F, Obara T, et al. Patterns of chromosomal imbalances in parathyroid carcinomas. Am J Pathol 157:570\u20136, 2000.","journal-title":"Am J Pathol"},{"key":"9050_CR17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00000478-200405000-00003","volume":"38","author":"LA Erickson","year":"2004","unstructured":"Erickson LA, Jalal SM, Harwood A, Sherer B, Jin L, Lloyd RV. Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization. Am J Surg Pathol 38:578\u20134, 2004. doi: 10.1097\/00000478-200405000-00003 .","journal-title":"Am J Surg Pathol"},{"key":"9050_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/path.1489","volume":"202","author":"CJ Haven","year":"2004","unstructured":"Haven CJ, van Puijenbroek M, Karperien M, Fleuren GJ, Morreau H. Differential expression of the calcium sensing receptor and combined loss of chromosome 1p and 11q in parathyroid carcinoma. J Pathol 202:86\u20134, 2004. doi: 10.1002\/path.1489 .","journal-title":"J Pathol"},{"key":"9050_CR19","first-page":"727","volume":"21","author":"S Valimaki","year":"2002","unstructured":"Valimaki S, Forsberg L, Farnebo LO, Larsson C. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas. Int J Oncol 21:727\u20135, 2002.","journal-title":"Int J Oncol"},{"key":"9050_CR20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199403173301105","volume":"330","author":"VT Cryns","year":"1994","unstructured":"Cryns VT, Thor A, Xu HJ. Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. N Engl J Med 330:757\u20131, 1994. doi: 10.1056\/NEJM199403173301105 .","journal-title":"N Engl J Med"},{"key":"9050_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2265.1996.d01-1561.x","volume":"45","author":"SH Pearce","year":"1996","unstructured":"Pearce SH, Trump D, Wooding C, Sheppard MN, Clayton RN, Thakker RV. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility BRCA2 loci in pituitary, parathyroid, pancreatic and carcinoid tumors. Clin Endocrinol (Oxf) 45:195\u2013200, 1996. doi: 10.1046\/j.1365-2265.1996.d01-1561.x .","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9050_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2265.2004.01954.x","volume":"60","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Viacava P, et al. A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid carcinoma. Clin Endocrinol (Oxf) 60:99\u2013106, 2004. doi: 10.1111\/j.1365-2265.2004.01954.x .","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9050_CR23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2265.2003.01814.x","volume":"59","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Kim TS, Costa J, et al. Mutational analysis of RB and BRCA2 as candidate tumor suppressor genes in parathyroid carcinomas. Clin Endocrinol (Oxf) 59:180\u20139, 2003. doi: 10.1046\/j.1365-2265.2003.01814.x .","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9050_CR24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, et al. HRPT2 encoding parafibromin is mutated in hyperparathyroidism\u2013jaw tumor syndrome. Nat Genet 32:676\u201380, 2002. doi: 10.1038\/ng1048 .","journal-title":"Nat Genet"},{"key":"9050_CR25","first-page":"228","volume-title":"Pathology and genetics of tumours of endocrine organs (WHO classification).","author":"BT Teh","year":"2004","unstructured":"Teh BT, Sweet KM, Morrison CD. Hyperparathyroidism\u2013jaw tumor syndromeIn: DeLellis RA, Lloyd RV, Heitz PN, Eng C, eds. Pathology and genetics of tumours of endocrine organs (WHO classification).. Lyon: IARC, pp. 228\u20139, 2004."},{"key":"9050_CR26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumors. J Med Genet 40:657\u20133, 2003. doi: 10.1136\/jmg.40.9.657 .","journal-title":"J Med Genet"},{"key":"9050_CR27","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T, et al. somatic and germline mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722\u201329, 2003. doi: 10.1056\/NEJMoa031237 .","journal-title":"N Engl J Med"},{"key":"9050_CR28","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","volume":"10","author":"MH Tan","year":"2004","unstructured":"Tan MH, Morrison C, Wang P, et al. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10:6629\u20137, 2004. doi: 10.1158\/1078-0432.CCR-04-0493 .","journal-title":"Clin Cancer Res"},{"key":"9050_CR29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","volume":"13","author":"C Juhlin","year":"2006","unstructured":"Juhlin C, Larsson C, Yakoleva T, et al. Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer 13:509\u20133, 2006. doi: 10.1677\/erc.1.01058 .","journal-title":"Endocr Relat Cancer"},{"key":"9050_CR30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O, et al. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism\u2013jaw tumor associated adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30:1140\u201349, 2006. doi: 10.1097\/01.pas.0000209827.39477.4f .","journal-title":"Am J Surg Pathol"},{"key":"9050_CR31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P, et al. Should parafibromin staining replace HRPT2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma. Europ J Endocrinol 156:547\u20134, 2007. doi: 10.1530\/EJE-06-0720 .","journal-title":"Europ J Endocrinol"},{"key":"9050_CR32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","volume":"14","author":"CC Juhlin","year":"2007","unstructured":"Juhlin CC, Villablanca A, Sandelin K, et al. Parafibromin immunoreactivity; its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer 14:501\u20132, 2007. doi: 10.1677\/ERC-07-0021 .","journal-title":"Endocr Relat Cancer"},{"key":"9050_CR33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00268-007-9458-8","volume":"32","author":"Y Tominaga","year":"2008","unstructured":"Tominaga Y, Tsuzuki T, Matsuoka A, et al. Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease. World J Surg 32:815\u20131, 2008. doi: 10.1007\/s00268-007-9458-8 .","journal-title":"World J Surg"},{"key":"9050_CR34","first-page":"108A","volume":"21","author":"S Mangray","year":"2008","unstructured":"Mangray S, Kurek KC, Sabo E, DeLellis RA. Immunohistochemical expression of parafibromin is of limited value in distinguishing parathyroid carcinoma from adenoma. Mod Pathol 21:108A, 2008, (abstract).","journal-title":"Mod Pathol"},{"key":"9050_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PAP.0b013e3181709f83","volume":"15","author":"S Mangray","year":"2008","unstructured":"Mangray S, DeLellis RA. Parafibromin s a tool for the diagnosis of parathyroid tumors (letter). Adv Anat Pathol 15:179, 2008. doi: 10.1097\/PAP.0b013e3181709f83 .","journal-title":"Adv Anat Pathol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-008-9050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-008-9050-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-008-9050-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T21:38:28Z","timestamp":1632519508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-008-9050-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9050"],"URL":"https:\/\/doi.org\/10.1007\/s12022-008-9050-2","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}